Nicoya Life Sciences launches multichannel benchtop SPR instrument

Nicoya Life Sciences, Inc., has launched Revo™, a label-free binding kinetics platform designed to make gold-standard surface plasmon resonance (SPR) data more accessible to a broader range of researchers.

By combining the precision of SPR with the simplicity and usability researchers expect from modern benchtop systems, Revo enables teams to generate publication-quality interaction data without the cost, complexity, or specialized expertise traditionally associated with SPR.

Revo was developed to address a longstanding gap in the industry: the need for a biomolecular interaction analysis platform that delivers reliable, high-quality data while fitting seamlessly into real-world laboratory environments.

The four-channel Revo™ system supports measurements in complex media, minimizes maintenance requirements, and offers a space- and cost-efficient alternative to traditional SPR instruments – empowering more teams to make confident, data-driven decisions earlier in drug and vaccine development.

Revo combines digital microfluidics (DMF) with nanotechnology-based biosensors, housed within a disposable cartridge, eliminating the need for ongoing fluidics maintenance. Each cartridge supports up to 18 total interactions, generating up to 90 individual binding curves per assay, the same capacity as a 96-well plate.

Key benefits of the platform include:

• High-quality, reproducible SPR data with minimal hands-on time
• 2 µL sample volume requirements, helping labs conserve valuable reagents
• Compatibility with crude samples, enabling real-world workflows
• Automated sample and buffer handling, including serial dilutions, reducing hands-on time by up to 70%
• Flexible assay configurations, chemistries, and functionalized cartridge options, including carboxyl and streptavidin surfaces
• Compact, benchtop footprint suitable for startups, academic labs, and translational research environments

Comprehensive software further simplifies assay setup and analysis, enabling straightforward access to kinetics, affinity, screening, and quantitation assays, without the need for specialized SPR expertise.

Revo offers a scalable four- to eight-channel throughput designed for labs that need high-quality interaction data without the scale or investment required for higher-throughput platforms. Multiple pricing and throughput options allow customers to scale up or down as their research evolves, while maintaining consistent data quality across Nicoya’s platform.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>